Physician profile
Bryan J Tigner
NPI 1578513297
$2,711.41
in general payments reported to CMS, 2019-2025
17 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $223 · 2021: $252 · 2022: $292 · 2023: $603 · 2024: $824 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525 · Travel and Lodging: $218 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.29 |
| Travel and Lodging | $217.56 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $742.68 | 2023-2025 | Inspire |
| Optinose US, INC. | $556.29 | 2020-2025 | |
| Glaxosmithkline, LLC. | $423.88 | 2021-2025 | Nucala |
| Genzyme Corporation | $297.47 | 2021-2025 | |
| Acclarent, INC | $172.67 | 2019-2023 | Acclarent Aera |
| Aerin Medical INC. | $98.86 | 2024 | |
| Stryker Corporation | $75.78 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $71.30 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $63.99 | 2019-2021 | |
| Amgen INC. | $49.49 | 2025 | |
| Genentech USA, INC. | $34.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $31.83 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $22.58 | 2024 | Acclarent Aera |
| Hospira, INC. | $20.84 | 2024 | |
| Kaleo, INC. | $17.25 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $17.03 | 2025 | Neffy |
| Alk-Abello, INC | $14.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Tigner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.